CEQUENT PHARMACEUTICALS

cequent-pharmaceuticals-logo

An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases รขโ‚ฌโ€œ from inflammatory diseases to cancer รขโ‚ฌโ€œ based on the company's proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent's first products, now in pre-clinical development, are drug candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful tkRNAi technology to deac... tivate specific disease-causing genes safely and effectively, using non-pathogenic bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut Pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/Harvard Medical School. A privately held company based in Cambridge, Massachusetts, Cequent was established in 2006. In July 2010, Cequent Pharmaceuticals was acquired by Marina Biotech, Inc (formerly MDRNA, Inc) for $46M.

#SimilarOrganizations #People #Financial #Website #More

CEQUENT PHARMACEUTICALS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2006-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.cequentpharma.com

Total Employee:
11+

Status:
Active

Contact:
617-995-7940

Email Addresses:
[email protected]

Total Funding:
12.4 M USD

Technology used in webpage:
SPF Domain Not Resolving OVH


Similar Organizations

vigeo-therapeutics-logo

Vigeo Therapeutics

Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.

Current Employees Featured

johannes-fruehauf_image

Johannes Fruehauf
Johannes Fruehauf Co-Founder @ Cequent Pharmaceuticals
Co-Founder

Founder


johannes-fruehauf_image

Johannes Fruehauf

Investors List

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Cequent Pharmaceuticals

nexus-medical-partners_image

Nexus Medical Partners

Nexus Medical Partners investment in Series A - Cequent Pharmaceuticals

ampersand-ventures_image

Ampersand Capital Partners

Ampersand Capital Partners investment in Series A - Cequent Pharmaceuticals

pappas-ventures_image

Pappas Ventures

Pappas Ventures investment in Series A - Cequent Pharmaceuticals

Official Site Inspections

http://www.cequentpharma.com

  • Host name: ip79.ip-144-217-233.net
  • IP address: 144.217.233.79
  • Location: Beauharnois Canada
  • Latitude: 45.3161
  • Longitude: -73.8736
  • Timezone: America/Toronto
  • Postal: J6N

Loading ...

More informations about "Cequent Pharmaceuticals" on Search Engine